RON-BIGGER SHULAMIT (Chief Operating Officer) sold 50K shares of AKTIS ONCOLOGY, INC. on the open market
Open‑market sale worth $1.39M. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 7/10/2026ACC: 0001193125-26-300163
Officer· Chief Operating Officer
Since Jan 2026
-50K
Net shares
Net seller
$1.39M
Total sold
3
Open market trades
0B · 3S
5
Total transactions
50K acquired · 100K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+50K
Price / share
$3.66
Trade value
$183K
% of position
New position
7/8/2026
0.00→50K
Common Stock
Direct
Shares
−15.80K
Price / share
$27.13
Trade value
$428.68K
% of position
31.6%
7/8/2026
50K→34.20K
Common Stock
Direct
Shares
−30K
Price / share
$27.94
Trade value
$838.14K
% of position
87.7%
7/8/2026
34.20K→4.20K
Common Stock
Direct
Shares
−4.20K
Price / share
$28.75
Trade value
$120.74K
% of position
New position
7/8/2026
4.20K→0.00
Total
Net shares
+0.00
Net value
-$1.20M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/8/2026 | M · Option Exercise | +50K | $3.66 | $183K | New position | 0.00 | 50K |
| Common Stock Direct | 7/8/2026 | S · Sale | −15.80K | $27.13 | $428.68K | 31.6% | 50K | 34.20K |
| Common Stock Direct | 7/8/2026 | S · Sale | −30K | $27.94 | $838.14K | 87.7% | 34.20K | 4.20K |
| Common Stock Direct | 7/8/2026 | S · Sale | −4.20K | $28.75 | $120.74K | New position | 4.20K | 0.00 |
| Total | +0.00 | -$1.20M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
50K shares
Shares
−50K
Strike price
3.66
Held after
217.89K
Exercisable
—
7/8/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock50K shares | 7/8/2026 | M · Option Exercise | −50K | 3.66 | — | 217.89K |